191 related articles for article (PubMed ID: 19616448)
1. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.
Tagaya M; Oka M; Ueda M; Takagaki K; Tanaka M; Ohgi T; Yano J
Cytokine; 2009 Sep; 47(3):185-93. PubMed ID: 19616448
[TBL] [Abstract][Full Text] [Related]
2. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.
Oka M; Fukui T; Ueda M; Tagaya M; Oyama T; Tanaka M
J Urol; 2009 Jul; 182(1):382-90. PubMed ID: 19447421
[TBL] [Abstract][Full Text] [Related]
3. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
[TBL] [Abstract][Full Text] [Related]
4. Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying.
Kawai Y; Oka M; Kyotani J; Oyama T; Matsumoto S; Kakizaki H
Neurourol Urodyn; 2013 Sep; 32(7):1031-7. PubMed ID: 23143863
[TBL] [Abstract][Full Text] [Related]
5. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
Matsumoto S; Hanai T; Matsui T; Oka M; Tanaka M; Uemura H
Phytother Res; 2010 Feb; 24(2):301-3. PubMed ID: 19585469
[TBL] [Abstract][Full Text] [Related]
6. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
[TBL] [Abstract][Full Text] [Related]
7. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
[TBL] [Abstract][Full Text] [Related]
8. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
9. Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis.
Tsunemori H; Sugimoto M; Xia Z; Taoka R; Oka M; Kakehi Y
Urology; 2011 Jun; 77(6):1507.e15-20. PubMed ID: 21624608
[TBL] [Abstract][Full Text] [Related]
10. Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Matsui T; Oka M; Fukui T; Tanaka M; Oyama T; Sagawa K; Nomiya M; Yamaguchi O
Int J Urol; 2012 Jul; 19(7):669-75. PubMed ID: 22458726
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
Sugaya K; Nishijima S; Tasaki S; Kadekawa K; Miyazato M; Ogawa Y
J Urol; 2008 Feb; 179(2):770-4. PubMed ID: 18082195
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling.
Yono M; Foster HE; Shin D; Mane S; Latifpour J
Life Sci; 2005 Jun; 77(4):470-9. PubMed ID: 15894016
[TBL] [Abstract][Full Text] [Related]
13. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
[TBL] [Abstract][Full Text] [Related]
14. Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation.
Li K; Yao J; Chi Y; Sawada N; Araki I; Kitamura M; Takeda M
Int J Mol Sci; 2013 Jun; 14(6):12107-22. PubMed ID: 23743824
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets of doxazosin in human prostatic stromal cells.
Zhao H; Lai F; Nonn L; Brooks JD; Peehl DM
Prostate; 2005 Mar; 62(4):400-10. PubMed ID: 15378519
[TBL] [Abstract][Full Text] [Related]
16. Global analysis of gene expression profiles in ileum in a rat bladder augmentation model using cDNA microarrays.
Miyake H; Hara S; Eto H; Kamidono S; Hara I
Int J Urol; 2004 Nov; 11(11):1009-12. PubMed ID: 15509206
[TBL] [Abstract][Full Text] [Related]
17. Effects of Scutellariae Radix on gene expression in HEK 293 cells using cDNA microarray.
Chen CS; Chen NJ; Lin LW; Hsieh CC; Chen GW; Hsieh MT
J Ethnopharmacol; 2006 May; 105(3):346-51. PubMed ID: 16406416
[TBL] [Abstract][Full Text] [Related]
18. Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia.
Oka M; Tachibana M; Noda K; Inoue N; Tanaka M; Kuwabara K
Phytomedicine; 2007 Aug; 14(7-8):465-72. PubMed ID: 17583488
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].
Naruoka T; Suzuki Y; Furuta A; Endo K; Sugaya S; Egawa S
Hinyokika Kiyo; 2008 May; 54(5):341-4. PubMed ID: 18546857
[TBL] [Abstract][Full Text] [Related]
20. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Kramer G; Marberger M
Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
